190 filings
10-Q
2024 Q1
EOLS
Evolus Inc
Quarterly report
7 May 24
5:00pm
8-K
EOLS
Evolus Inc
7 May 24
Evolus Reports First Quarter 2024 Results and Provides Business Update
4:14pm
DEFA14A
EOLS
Evolus Inc
26 Apr 24
Additional proxy soliciting materials
4:56pm
DEF 14A
EOLS
Evolus Inc
Definitive proxy
26 Apr 24
4:55pm
ARS
2023 FY
EOLS
Evolus Inc
26 Apr 24
Annual report to shareholders
4:55pm
8-K
rnla5
3 Apr 24
Departure of Directors or Certain Officers
4:29pm
8-K
qcbyafn 155c
13 Mar 24
Entry into a Material Definitive Agreement
4:59pm
424B5
dg976h56ynn5vzh9la
11 Mar 24
Prospectus supplement for primary offering
9:00am
S-8
i80ig 6uiny5nrhw
7 Mar 24
Registration of securities for employees
4:58pm
8-K
nzv6tg8vjla4we4
7 Mar 24
Evolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 Guidance
4:09pm
8-K
9c28r
16 Jan 24
Evolus Announces Preliminary Unaudited Fourth Quarter
5:28pm
8-K
0mhqz80m rxeq
20 Dec 23
Evolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Dermal Fillers in Europe
8:33am
8-K
cv1v08o56d8rnn54
7 Nov 23
Evolus Reports Record Third Quarter 2023 Financial Results
4:24pm
S-8
lriihnjyqh82h hez
6 Oct 23
Registration of securities for employees
5:27pm
8-K
q5qn1lvz z4mw
2 Aug 23
Evolus Reports Second Quarter 2023 Results
4:08pm
8-K
85k2oqd7ef4fptbc4
27 Jul 23
Results of Operations and Financial Condition
8:55am
8-K
8v4c1fnriip8
14 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:39pm